Trademark: 79246377
Word
OOCUITY
Status
Registered
Status Code
700
Status Date
Tuesday, July 23, 2019
Serial Number
79246377
Registration Number
5809477
Registration Date
Tuesday, July 23, 2019
Mark Type
4000
Filing Date
Monday, September 10, 2018
Published for Opposition
Tuesday, May 7, 2019

Trademark Owner History
NANOBIOTIX - Original Registrant

Classifications
5 Pharmaceutical products for medical use, namely, for the treatment of brain diseases and disorders; Pharmaceutical preparation for the diagnosis and treatment of brain diseases and disorders; Pharmaceutical preparation for medical use namely, for modifying the bioavailability of therapeutic agents; Pharmaceutical preparation for medical use namely, for the diagnosis and treatment of tumors; Pharmaceutical preparation for medical use particularly for the treatment of Parkinson's disease, Alzheimer's disease, epilepsy and all types of neurological and neuropsychiatric diseases and disorders; Pharmaceutical preparation for medical use namely, for [ the treatment of ] * treating the * symptoms of Parkinson's disease, symptoms of Alzheimer's disease, symptoms of epilepsy and symptoms [ relating to all kinds ] * related to any type * of neurological and neuropsychiatric [ diseases and disorders ] * disorders and diseases * ; Pharmaceutical preparation for the diagnosis and treatment of neurological disorders and diseases for use with deep brain stimulation, electrical transcranial stimulation, transcranial direct-current stimulation, transcranial magnetic stimulation, any form of electromagnetic stimulation in the nature of light, magnetic field, electric field, radio frequency or ultrasound stimulation; health * care * products, namely, pharmaceutical preparations for central nervous systems disorder treatment; radiological contrast substances for medical use; nanoparticles for medical use, namely, nanomaterial-based chemical preparations for medical and pharmaceutical purpose for the treatment of cancer, central nervous system disorder, cardiovascular, immunological, gastrointestinal, metabolic and infectious diseases ; Drug delivery agents in the form of nanomaterial-based preparation for the delivery of therapeutic agents; chemical reagents for medical use; bacteriological preparations for medical use; biological preparations for medical use, namely, for the treatment of cancer, central nervous system disorder, cardiovascular, immunological, gastrointestinal, metabolic and infectious diseases; enzymes for medical use; enzyme preparations for medical use; chemical preparations for medical or pharmaceutical use, namely, for the treatment of cancer, central nervous system disorders, cardiovascular, immunological, gastrointestinal, metabolic and infectious diseases; diagnostic products for medical use, namely, diagnostic preparations for medical purposes; drugs for medical use, namely, nanomaterial-based pharmaceutical preparation of active ingredients for the treatment of cancer, central nervous system disorders, cardiovascular, immunological, gastrointestinal, metabolic and infectious diseases; medicines for human medicine, namely, medical preparations for the treatment of cancer, central nervous system disorders, cardiovascular, immunological, gastrointestinal, metabolic and infectious diseases; tonics being medicines, namely, medicinal herbal preparations; antibiotics; antiseptics; chemico-pharmaceutical products, namely, chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of cancer, central nervous system disorders, cardiovascular, immunological, gastrointestinal, metabolic and infectious diseases; pharmaceutical products, namely, pharmaceutical products for the treatment of cancer, central nervous system disorders, cardiovascular, immunological, gastrointestinal, metabolic and infectious diseases * for human use * ; dietetic substances for medical use, namely, dietetic foods adapted for medical purposes; remedies for human medicine, namely, natural remedy preparations for the treatment of gastrointestinal conditions, hormonal and chemical imbalances, and sleep disorder
44 Healthcare especially in the field of nanomedicine; medical services especially in the field of nanomedicine; hospital services; medical assistance; physiotherapy
10 [ Surgical and medical apparatus and instruments especially for the diagnosis and treatment of tumors, namely, surgical apparatus and instruments for use in oncologic surgery, lasers for surgical and medical use, medical imaging devices, namely, ultrasound imaging apparatus, scanners and needle guides, and parts and fittings therefor; surgical and medical apparatus and instruments especially for monitoring and modifying metabolic functions, namely, heart rate monitoring apparatus, medical apparatus and instruments for monitoring vital signs, blood properties and respiratory events, devices for monitoring blood glucose for medical purposes; surgical and medical apparatus and instruments especially for the diagnosis and treatment of brain diseases and disorders, namely, medical imaging devices for the brain, medical devices for monitoring vital signs, blood properties and respiratory events, medical devices for monitoring brain's electrical activity, medical devices for monitoring cognitive and motor functions during neurosurgery, medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of neurodegenerative diseases; surgical apparatus and instruments for deep brain stimulation, electrical transcranial stimulation, transcranial direct-current stimulation, transcranial magnetic stimulation, any form of electromagnetic stimulation, namely, light, magnetic field, electric field, radio frequency or ultrasound stimulation, namely, low level laser therapy, near-infrared light-emitting devices, electric devices for deep brain stimulation, wire coil devices for magnetic stimulation, scalp electrodes for transcranial direct-current stimulation, medical radiofrequency apparatus, medical ultrasound apparatus, electrical stimulation apparatus for scalp, nerves, skin, and muscles for physical therapy purposes; apparatus for the delivery of diagnostic or therapeutic agents, namely, medical apparatus and units for dosage, measuring and monitoring, namely, drug delivery devices and systems and organ oxygenation and perfusion apparatus; testing apparatus for medical use, namely, medical imaging devices for monitoring oxygen level in the brain, medical imaging devices for monitoring glucose level in the brain, medical imaging devices for monitoring proteins level in the brain, microdialysis devices for monitoring proteins level in the cerebrospinal fluid, medical devices for monitoring the brain's electrical activity; diagnostic apparatus for medical use, namely, medical diagnostic apparatus for testing the brain's electrical activity, oxygen level in the brain, glucose level in the brain, proteins level in the brain; Medical apparatus for the recording of electrical brain activity, namely, electrodes, electroencephalograph, micro-electrode arrays; apparatus for electrophysiology, namely, medical electrodes for patch-clamp devices, current-clamp devices, voltage-clamp devices, micro-electrode arrays devices; apparatus for neuronal modeling, namely, medical imaging apparatus incorporating medical imaging software and computational software sold as a unit therewith ]
42 Scientific and technological services namely, scientific research and research and design in the field of nanomedicine in the nature of nanotechnology applied to medicine; biological research services; bacteriological research services; electrophysiological research; research in neuronal modeling; Testing, analysis and evaluation of service providers to determine conformity with established accreditation standards, namely, evaluations, estimates and research in scientific and technological fields provided by engineers and researchers; design and development of new products for third parties; technical project studies, namely, technical research in the field of pharmaceutical project studies; industrial analysis and research services in the field of biomedical research; chemical analysis; chemical research; chemistry services, namely, chemistry consultation; surveying, namely, conducting engineering surveys; research and development of new products for others; technical research in the field of pharmaceutical studies; research in the field of neuroscience; research in radio-biology; research in nanoscience and nanotechnology, especially applied to medicine
In the statement, class 9 has been corrected per the Restriction dated May 30, 2019, and per the Fnote dated October 6, 2019.
In the Heading and In the Statement, Int. Cls.: 10 should be deleted.

Trademark Events
Mar 31, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Mar 31, 2023
Teas Change Of Correspondence Received
Mar 31, 2023
Teas Change Of Domestic Representatives Address
Mar 31, 2023
Teas Withdrawal Of Attorney Received-Firm Retains
Mar 31, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Mar 31, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Mar 31, 2023
Teas Change Of Owner Address Received
Jul 11, 2020
Invalidation Reviewed - No Action Required By Office
Jun 23, 2020
Partial Invalidation Of Reg Ext Protection Created
Mar 9, 2020
Limitation From The Ib Examined And Entered
Mar 7, 2020
Correction Under Section 7 ¿ Processed
Nov 22, 2019
Final Decision Transaction Processed By Ib
Nov 2, 2019
Final Disposition Notice Sent To Ib
Nov 2, 2019
Final Disposition Processed
Nov 1, 2019
Limitation Of Goods Received From Ib
Oct 23, 2019
Final Disposition Notice Created, To Be Sent To Ib
Oct 17, 2019
Limitation From The Ib Examined And Entered
Oct 16, 2019
Correction Under Section 7 ¿ Processed
Oct 16, 2019
Assigned To Paralegal
Jul 23, 2019
Registered-Principal Register
May 31, 2019
Limitation Of Goods Received From Ib
May 7, 2019
Published For Opposition
May 3, 2019
Notification Processed By Ib
Apr 17, 2019
Notification Of Possible Opposition Sent To Ib
Apr 17, 2019
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Apr 17, 2019
Notice Of Publication
Mar 25, 2019
Approved For Pub - Principal Register
Mar 25, 2019
Examiners Amendment Mailed
Mar 22, 2019
Examiner's Amendment Entered
Mar 22, 2019
Examiners Amendment -Written
Mar 15, 2019
Attorney/Dom.Rep.Revoked And/Or Appointed
Mar 15, 2019
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jan 25, 2019
Refusal Processed By Ib
Jan 5, 2019
Non-Final Action Mailed - Refusal Sent To Ib
Jan 5, 2019
Refusal Processed By Mpu
Dec 20, 2018
Non-Final Action (Ib Refusal) Prepared For Review
Dec 19, 2018
Non-Final Action Written
Dec 19, 2018
Assigned To Examiner
Dec 4, 2018
Application Filing Receipt Mailed
Nov 30, 2018
New Application Office Supplied Data Entered
Nov 29, 2018
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24